Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Elanco Animal Health Inc (NY: ELAN )

12.60 -0.04 (-0.32%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Elanco Animal Health to Contact Us to Have Their Losses Evaluated Today
From Faruqi & Faruqi LLP
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
Evaluating Elanco Animal Health: Insights From 4 Financial Analysts
Via Benzinga
Demystifying Elanco Animal Health: Insights From 4 Analyst Reviews
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Elanco, Domino’s, and iLearningEngines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Elanco Animal Health Incorporated Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Faruqi & Faruqi Reminds Elanco Animal Health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 6, 2024 - ELAN
From Faruqi & Faruqi LLP
Via GlobeNewswire
ELAN CLASS ACTION NEWS: Elanco Animal Health Incorporated Shareholders with Large Losses Should Seek Counsel; Contact Robbins LLP for Information About the Pending Class Action
From Robbins LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Elanco, Edwards, and UPS and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Reminds Elanco Animal Health Incorporated (ELAN) Investors of Class Action Filing and Encourages Investors to Contact the Firm
From Kirby McInerney LLP
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN
From The Rosen Law Firm PA
Via GlobeNewswire
ELAN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Elanco Animal Health Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Elanco Animal Health Incorporated Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Elanco and UPS and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ELAN Class Action Notice: Robbins LLP Reminds Shareholders of the Lead Plaintiff Deadline in the Class Action Against Elanco Animal Health Incorporated
From Robbins LLP
Via GlobeNewswire
ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Elanco Animal Health Incorporated Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ELAN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
ELAN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Elanco Animal Health Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ROSEN, A LEADING AND RANKED FIRM, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN
From The Rosen Law Firm PA
Via GlobeNewswire
ELAN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN
From The Rosen Law Firm PA
Via GlobeNewswire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Elanco Animal Health Incorporated (ELAN) Investors
From Kirby McInerney LLP
Via Business Wire
ELANCO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elanco Animal Health Incorporated and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Elanco Animal Health Incorporated
From Robbins LLP
Via GlobeNewswire
ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Rosen Law Firm Urges Elanco Animal Health Incorporated (NYSE: ELAN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) INVESTOR ALERT: Investors With Large Losses in Elanco Animal Health Incorporated Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic dermatitis. The drug, proven effective in studies, faces adoption challenges due to... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.